首页 > 最新文献

Expert review of medical devices最新文献

英文 中文
Total-body PET/CT: how will it change theranostics in oncology? 全身PET/CT:它将如何改变肿瘤学的治疗?
Pub Date : 2023-07-01 Epub Date: 2023-11-24 DOI: 10.1080/17434440.2023.2281660
Luca Filippi, Nicoletta Urbano, Orazio Schillaci
{"title":"Total-body PET/CT: how will it change theranostics in oncology?","authors":"Luca Filippi, Nicoletta Urbano, Orazio Schillaci","doi":"10.1080/17434440.2023.2281660","DOIUrl":"10.1080/17434440.2023.2281660","url":null,"abstract":"","PeriodicalId":94006,"journal":{"name":"Expert review of medical devices","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71490421","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recent advances in the direct anterior approach to total hip arthroplasty: a surgeon's perspective. 直接前路全髋关节置换术的最新进展:外科医生的观点。
Pub Date : 2023-07-01 Epub Date: 2023-11-24 DOI: 10.1080/17434440.2023.2280986
Yasuhiro Homma, Tomonori Baba, Taiji Watari, Koju Hayashi, Hideo Kobayashi, Mikio Matsumoto, Sammy Banno, Yu Ozaki, Hironori Ochi, Yuta Jinnai, Seiya Ishii, Hiroki Tanabe, Yuichi Shirogane, Xu Zhuang, Takahito Yuasa, Kazuo Kaneko, Muneaki Ishijima

Introduction: The direct anterior approach (DAA) has its origins in the first and oldest approach for hip replacement in the literature, but at the same time it would not be fanciful to suggest its increasing popularity as the latest approach for hip replacement procedures, especially among younger surgeons. However, in a geographical context, the DAA is not considered the major approach in most countries. Moreover, the term DAA encompasses numerous variations in terms of technique.

Areas covered: In this narrative review, we describe our recent experience of advances in the DAA in terms of improved techniques and devices, along with some of its disadvantages. Also, we express our perspective on its future application.

Expert opinions: The DAA is established as one of exemplary approaches to THA. The use of fluoroscopy, the traction table, and appropriate soft tissue management has become essential in the DAA for a safe and trouble-free procedure with adequate patient comfort. With the combination of recent technologies such as robotics, three-dimensional preoperative planning, and artificial intelligence (AI)-based surgeon assist systems, we can look forward to the DAA being performed more efficiently in the future.

引言:直接前路入路(DAA)起源于文献中第一种也是最古老的髋关节置换术,但同时,它作为髋关节置换手术的最新方法越来越受欢迎,尤其是在年轻外科医生中,这也不是异想天开。然而,从地理角度来看,DAA并不是大多数国家的主要方法。此外,术语DAA在技术方面包括许多变体。涵盖的领域:在这篇叙述性综述中,我们描述了DAA在改进技术和设备方面的最新进展经验,以及它的一些缺点。此外,我们表达了我们对其未来应用的看法。专家意见:DAA是THA的典型方法之一。荧光镜检查、牵引台和适当的软组织管理在DAA中的使用已变得至关重要,以实现安全、无故障的手术,并使患者感到足够舒适。随着机器人技术、三维术前规划和基于人工智能(AI)的外科医生辅助系统等最新技术的结合,我们可以期待DAA在未来更有效地执行。
{"title":"Recent advances in the direct anterior approach to total hip arthroplasty: a surgeon's perspective.","authors":"Yasuhiro Homma, Tomonori Baba, Taiji Watari, Koju Hayashi, Hideo Kobayashi, Mikio Matsumoto, Sammy Banno, Yu Ozaki, Hironori Ochi, Yuta Jinnai, Seiya Ishii, Hiroki Tanabe, Yuichi Shirogane, Xu Zhuang, Takahito Yuasa, Kazuo Kaneko, Muneaki Ishijima","doi":"10.1080/17434440.2023.2280986","DOIUrl":"10.1080/17434440.2023.2280986","url":null,"abstract":"<p><strong>Introduction: </strong>The direct anterior approach (DAA) has its origins in the first and oldest approach for hip replacement in the literature, but at the same time it would not be fanciful to suggest its increasing popularity as the latest approach for hip replacement procedures, especially among younger surgeons. However, in a geographical context, the DAA is not considered the major approach in most countries. Moreover, the term DAA encompasses numerous variations in terms of technique.</p><p><strong>Areas covered: </strong>In this narrative review, we describe our recent experience of advances in the DAA in terms of improved techniques and devices, along with some of its disadvantages. Also, we express our perspective on its future application.</p><p><strong>Expert opinions: </strong>The DAA is established as one of exemplary approaches to THA. The use of fluoroscopy, the traction table, and appropriate soft tissue management has become essential in the DAA for a safe and trouble-free procedure with adequate patient comfort. With the combination of recent technologies such as robotics, three-dimensional preoperative planning, and artificial intelligence (AI)-based surgeon assist systems, we can look forward to the DAA being performed more efficiently in the future.</p>","PeriodicalId":94006,"journal":{"name":"Expert review of medical devices","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71523948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recent advances in the use of ultrasound in Crohn's disease. 克罗恩病超声治疗的最新进展
Pub Date : 2023-07-01 Epub Date: 2023-11-24 DOI: 10.1080/17434440.2023.2283166
Alberto Barchi, Ferdinando D'Amico, Alessandra Zilli, Federica Furfaro, Tommaso Lorenzo Parigi, Gionata Fiorino, Laurent Peyrin-Biroulet, Silvio Danese, Arianna Dal Buono, Mariangela Allocca

Introduction: A clear consensus exists on the role of IUS for the assessment and monitoring of Crohn's disease (CD) in the 'treat-to-target' strategy.

Areas covered: IUS is an accurate tool for the management of CD. It is noninvasive and well tolerated. IUS has good-to-optimal inter-operator reliability either for assessing disease activity or for evaluating treatment response, especially combining Bowel Wall Thickness (BWT) and Color Doppler Signals (CDS). IUS is able to evaluate transmural remission (TR), the ultimate goal of the 'treat-to-target' strategy. Several studies confirmed its accuracy in the assessment of the post-operative recurrence (POR). Thanks to recent advances in trans-perineal ultrasound technique (TPUS), it allows to characterize peri-anal disease and its complications. Small intestine contrast ultrasound (SICUS) and contrast-enhancement ultrasound (CEUS) may improve IUS performance, particularly in stricturing or penetrating CD. Ultrasound elastography (USE) is raising interest for its accuracy in differentiating CD phenotypes (fibrotic versus inflamed).

Expert opinion: IUS is a pivotal step in the management of CD, in early assessment as in therapeutic monitoring, with advantages of evaluating transmural response. Development and validation of novel ultrasound biomarkers of activity and fibrosis, especially those linked to advanced ultrasound techniques, are expected in the coming years.

在“从治疗到目标”的战略中,IUS在评估和监测克罗恩病(CD)方面的作用已形成明确的共识。研究领域:IUS是治疗CD的准确工具,无创且耐受性良好。IUS在评估疾病活动性和评估治疗反应方面具有良好至最佳的操作者间可靠性,特别是结合肠壁厚度(BWT)和彩色多普勒信号(CDS)。IUS能够评估跨壁缓解(TR),这是“从治疗到靶向”策略的最终目标。几项研究证实了其在评估术后复发(POR)方面的准确性。由于经会阴超声技术(TPUS)的最新进展,它可以表征肛周疾病及其并发症。小肠对比超声(SICUS)和对比增强超声(CEUS)可以改善IUS的表现,特别是在狭窄性或穿透性CD中。超声弹性成像(USE)因其在区分CD表型(纤维化与炎症)方面的准确性而引起人们的兴趣。专家意见:IUS是乳糜泻管理的关键一步,无论是在早期评估还是在治疗监测中,都具有评估跨壁反应的优势。预计未来几年将开发和验证新的活性和纤维化超声生物标志物,特别是与先进的超声技术相关的生物标志物。
{"title":"Recent advances in the use of ultrasound in Crohn's disease.","authors":"Alberto Barchi, Ferdinando D'Amico, Alessandra Zilli, Federica Furfaro, Tommaso Lorenzo Parigi, Gionata Fiorino, Laurent Peyrin-Biroulet, Silvio Danese, Arianna Dal Buono, Mariangela Allocca","doi":"10.1080/17434440.2023.2283166","DOIUrl":"10.1080/17434440.2023.2283166","url":null,"abstract":"<p><strong>Introduction: </strong>A clear consensus exists on the role of IUS for the assessment and monitoring of Crohn's disease (CD) in the 'treat-to-target' strategy.</p><p><strong>Areas covered: </strong>IUS is an accurate tool for the management of CD. It is noninvasive and well tolerated. IUS has good-to-optimal inter-operator reliability either for assessing disease activity or for evaluating treatment response, especially combining Bowel Wall Thickness (BWT) and Color Doppler Signals (CDS). IUS is able to evaluate transmural remission (TR), the ultimate goal of the 'treat-to-target' strategy. Several studies confirmed its accuracy in the assessment of the post-operative recurrence (POR). Thanks to recent advances in trans-perineal ultrasound technique (TPUS), it allows to characterize peri-anal disease and its complications. Small intestine contrast ultrasound (SICUS) and contrast-enhancement ultrasound (CEUS) may improve IUS performance, particularly in stricturing or penetrating CD. Ultrasound elastography (USE) is raising interest for its accuracy in differentiating CD phenotypes (fibrotic versus inflamed).</p><p><strong>Expert opinion: </strong>IUS is a pivotal step in the management of CD, in early assessment as in therapeutic monitoring, with advantages of evaluating transmural response. Development and validation of novel ultrasound biomarkers of activity and fibrosis, especially those linked to advanced ultrasound techniques, are expected in the coming years.</p>","PeriodicalId":94006,"journal":{"name":"Expert review of medical devices","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"92158090","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Forced inspiratory suction and swallow tool (FISST): an automation of Valsalva maneuver variants for therapeutic interventions. 强制吸气和吞咽工具(FIST):用于治疗干预的Valsalva操作变体的自动化。
Pub Date : 2023-07-01 Epub Date: 2023-11-24 DOI: 10.1080/17434440.2023.2283167
Hari N Krishnakumar, Shwetha R Menon, Alireza Mirahmadizadeh, Ali Seifi

Introduction: The Valsalva maneuver and its modifications have been utilized across several conditions in medicine; however, there have been difficulties in its application. Thus, at the University of Texas Health Science Center in San Antonio, we designed and patented an affordable and accessible device that mimics Valsalva called "Forced Inspiratory Suction and Swallow Tool (FISST).

Areas covered: In this review, we discuss the premise for the design of FISST, based on applications of the law of conservation energy, the continuity equation, and Bernoulli's principle. We then detail the mechanism by which FISST stimulates hiccup cessation by increasing negative inspiratory pressure when drinking through the apparatus, causing diaphragmatic contraction and disruption of the hiccup reflex. We then detail the efficacy and future applications of FISST in addressing other pathologies.

Expert opinion: FISST has been used to address hiccups by utilizing its reverse-Valsalva effect to increase parasympathetic stimulation by increasing vagal tone. In a prospective study that we conducted on a cohort of 249 hiccup subjects worldwide, this tool achieved 92% effectiveness. Additionally, several cases, including a published case report, have found FISST successful in terminating supraventricular tachycardias (SVT). FISST may be further utilized in diagnosing or addressing various upper airway pathologies and should be explored further.

引言:瓦尔萨尔瓦策略及其修改已在医学的多种条件下使用;然而,它的应用一直存在困难。因此,在圣安东尼奥的得克萨斯大学健康科学中心,我们设计并申请了一种价格合理且易于使用的模仿瓦尔萨尔瓦的设备,名为“强制吸气和吞咽工具”(FIST)涵盖的领域:在这篇综述中,我们讨论了FIST设计的前提,基于守恒定律、连续性方程和伯努利原理的应用。然后,我们详细介绍了FIST刺激打嗝停止的机制,通过该设备饮酒时增加吸气负压,导致膈肌收缩和打嗝反射中断。然后,我们详细介绍了FIST在治疗其他病理方面的疗效和未来应用。专家意见:FIST已被用于解决打嗝,利用其反向瓦尔萨尔瓦效应,通过增加迷走神经张力来增加副交感神经刺激。在我们对全球249名打嗝受试者进行的一项前瞻性研究中,该工具的有效性达到92%。此外,一些病例,包括一份已发表的病例报告,发现FIST成功终止了室上性心动过速(SVT)。FIST可以进一步用于诊断或解决各种上呼吸道病理,并且应该进一步探索。
{"title":"Forced inspiratory suction and swallow tool (FISST): an automation of Valsalva maneuver variants for therapeutic interventions.","authors":"Hari N Krishnakumar, Shwetha R Menon, Alireza Mirahmadizadeh, Ali Seifi","doi":"10.1080/17434440.2023.2283167","DOIUrl":"10.1080/17434440.2023.2283167","url":null,"abstract":"<p><strong>Introduction: </strong>The Valsalva maneuver and its modifications have been utilized across several conditions in medicine; however, there have been difficulties in its application. Thus, at the University of Texas Health Science Center in San Antonio, we designed and patented an affordable and accessible device that mimics Valsalva called \"<i>Forced Inspiratory Suction and Swallow Tool</i> (FISST).</p><p><strong>Areas covered: </strong>In this review, we discuss the premise for the design of FISST, based on applications of the law of conservation energy, the continuity equation, and Bernoulli's principle. We then detail the mechanism by which FISST stimulates hiccup cessation by increasing negative inspiratory pressure when drinking through the apparatus, causing diaphragmatic contraction and disruption of the hiccup reflex. We then detail the efficacy and future applications of FISST in addressing other pathologies.</p><p><strong>Expert opinion: </strong>FISST has been used to address hiccups by utilizing its reverse-Valsalva effect to increase parasympathetic stimulation by increasing vagal tone. In a prospective study that we conducted on a cohort of 249 hiccup subjects worldwide, this tool achieved 92% effectiveness. Additionally, several cases, including a published case report, have found FISST successful in terminating supraventricular tachycardias (SVT). FISST may be further utilized in diagnosing or addressing various upper airway pathologies and should be explored further.</p>","PeriodicalId":94006,"journal":{"name":"Expert review of medical devices","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72016499","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mechanical complications after total knee arthroplasty. 全膝关节置换术后的机械并发症。
Pub Date : 2023-07-01 Epub Date: 2023-11-24 DOI: 10.1080/17434440.2023.2282744
Patrick Connolly, Stefan Coombs, Ran Schwarzkopf

Introduction: With the increasing demand for total knee arthroplasty (TKA) and the burden of revision TKA on the healthcare system, as well as the quality of life implications for patients, it is extremely important for surgeons to be able to anticipate and prevent TKA mechanical complications. Surgeons must be familiar with the different causes and mechanisms of TKA complications so that they can properly treat patients with failed TKAs and better avoid these complications.

Areas covered: This review addresses TKA mechanical complications and provides context for the topic. A detailed review of surgical factors, implant factors, and patient factors that contribute to mechanical complications after TKA is provided. All of the literature cited in this review was gathered from the PubMed online database using different keywords based on the section of the manuscript.

Expert opinion: As surgeons and engineers solve certain issues in TKA, new challenges will inevitably arise. We must continue to push forward and innovate from both a surgical technique and implant design perspective.

引言:随着对全膝关节置换术(TKA)的需求不断增加,医疗系统对TKA翻修的负担以及对患者生活质量的影响,外科医生能够预测和预防TKA机械并发症是极其重要的。外科医生必须熟悉TKA并发症的不同原因和机制,以便正确治疗TKA失败的患者,更好地避免这些并发症。涵盖的领域:这篇综述涉及TKA机械并发症,并提供了有关该主题的背景。对TKA术后导致机械并发症的手术因素、植入因素和患者因素进行了详细综述。这篇综述中引用的所有文献都是根据手稿的章节使用不同的关键词从PubMed在线数据库中收集的。专家意见:随着外科医生和工程师解决TKA中的某些问题,新的挑战将不可避免地出现。我们必须从外科技术和植入物设计的角度继续推进和创新。
{"title":"Mechanical complications after total knee arthroplasty.","authors":"Patrick Connolly, Stefan Coombs, Ran Schwarzkopf","doi":"10.1080/17434440.2023.2282744","DOIUrl":"10.1080/17434440.2023.2282744","url":null,"abstract":"<p><strong>Introduction: </strong>With the increasing demand for total knee arthroplasty (TKA) and the burden of revision TKA on the healthcare system, as well as the quality of life implications for patients, it is extremely important for surgeons to be able to anticipate and prevent TKA mechanical complications. Surgeons must be familiar with the different causes and mechanisms of TKA complications so that they can properly treat patients with failed TKAs and better avoid these complications.</p><p><strong>Areas covered: </strong>This review addresses TKA mechanical complications and provides context for the topic. A detailed review of surgical factors, implant factors, and patient factors that contribute to mechanical complications after TKA is provided. All of the literature cited in this review was gathered from the PubMed online database using different keywords based on the section of the manuscript.</p><p><strong>Expert opinion: </strong>As surgeons and engineers solve certain issues in TKA, new challenges will inevitably arise. We must continue to push forward and innovate from both a surgical technique and implant design perspective.</p>","PeriodicalId":94006,"journal":{"name":"Expert review of medical devices","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72212275","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anatomy of a Woebot® (WB001): agent guided CBT for women with postpartum depression. Woebot®解剖(WB001):药物指导下的产后抑郁症妇女CBT。
Pub Date : 2023-07-01 Epub Date: 2023-11-24 DOI: 10.1080/17434440.2023.2280686
Alison Darcy, Aaron Beaudette, Emil Chiauzzi, Jade Daniels, Kim Goodwin, Timothy Y Mariano, Paul Wicks, Athena Robinson

Introduction: Postpartum depression (PPD) is common, persistent, and stigmatized. There are insufficient trained professionals to deliver appropriate screening, diagnosis, and treatment.

Areas covered: WB001 is a Software as a Medical Device (SaMD) based Agent-Guided Cognitive-Behavioral Therapy (AGCBT) program for the treatment of PPD, for which Breakthrough Device Designation was recently granted by the US Food and Drug Administration. WB001 combines therapeutic alliance, human-centered design, machine learning techniques, and established principles from CBT and interpersonal therapy (IPT). We introduce AGCBT as a new model of service delivery, whilst describing Woebot, the agent technology that enables guidance through the replication of some elements of human relationships. The profile describes the device's design principles, enabling technology, risk handling, and efficacy data in PPD.

Expert opinion: WB001 is a dynamic and personalized tool with which patients may establish a therapeutic bond. Woebot is designed to augment (rather than replace) human healthcare providers, unlocking the therapeutic potency associated with guidance, whilst retaining the scalability and agency that characterizes self-help approaches. WB001 has the potential to improve both the quality and the scalability of care through providing support to patients on waiting lists, in between clinical encounters, and enabling automation of measurement-based-care.

引言:产后抑郁症(PPD)是常见的、持续的和污名化的。没有足够训练有素的专业人员来提供适当的筛查、诊断和治疗。涵盖领域:WB001是一个基于软件即医疗设备(SaMD)的代理引导认知行为疗法(AGCBT)项目,用于治疗PPD,美国食品和药物管理局最近授予了该项目的突破性设备指定。WB001结合了治疗联盟、以人为中心的设计、机器学习技术以及CBT和人际治疗(IPT)的既定原则。我们介绍了AGCBT作为一种新的服务交付模式,同时描述了Woebot,这是一种通过复制人际关系的一些元素来实现指导的代理技术。该简介描述了该设备的设计原理、启用技术、风险处理和PPD中的疗效数据。专家意见:WB001是一种动态和个性化的工具,患者可以通过它建立治疗联系。Woebot旨在增强(而不是取代)人类医疗保健提供者,释放与指导相关的治疗效力,同时保留自助方法的可扩展性和能动性。WB001有潜力通过为候诊名单上的患者提供支持,在临床接触之间提供支持,并实现基于测量的护理自动化,从而提高护理的质量和可扩展性。
{"title":"Anatomy of a Woebot® (WB001): agent guided CBT for women with postpartum depression.","authors":"Alison Darcy, Aaron Beaudette, Emil Chiauzzi, Jade Daniels, Kim Goodwin, Timothy Y Mariano, Paul Wicks, Athena Robinson","doi":"10.1080/17434440.2023.2280686","DOIUrl":"10.1080/17434440.2023.2280686","url":null,"abstract":"<p><strong>Introduction: </strong>Postpartum depression (PPD) is common, persistent, and stigmatized. There are insufficient trained professionals to deliver appropriate screening, diagnosis, and treatment.</p><p><strong>Areas covered: </strong>WB001 is a Software as a Medical Device (SaMD) based Agent-Guided Cognitive-Behavioral Therapy (AGCBT) program for the treatment of PPD, for which Breakthrough Device Designation was recently granted by the US Food and Drug Administration. WB001 combines therapeutic alliance, human-centered design, machine learning techniques, and established principles from CBT and interpersonal therapy (IPT). We introduce AGCBT as a new model of service delivery, whilst describing Woebot, the agent technology that enables guidance through the replication of some elements of human relationships. The profile describes the device's design principles, enabling technology, risk handling, and efficacy data in PPD.</p><p><strong>Expert opinion: </strong>WB001 is a dynamic and personalized tool with which patients may establish a therapeutic bond. Woebot is designed to augment (rather than replace) human healthcare providers, unlocking the therapeutic potency associated with guidance, whilst retaining the scalability and agency that characterizes self-help approaches. WB001 has the potential to improve both the quality and the scalability of care through providing support to patients on waiting lists, in between clinical encounters, and enabling automation of measurement-based-care.</p>","PeriodicalId":94006,"journal":{"name":"Expert review of medical devices","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71490417","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 12
Emerging transcatheter heart valve technologies for severe aortic stenosis. 新兴的经导管心脏瓣膜技术治疗严重主动脉瓣狭窄。
Pub Date : 2023-07-01 Epub Date: 2023-11-24 DOI: 10.1080/17434440.2023.2277229
Ahmed Elkoumy, Darren Mylotte, Hesham Elzomor, Angela McInerney, Osama Soliman

Introduction: Transcatheter aortic valve implantation (TAVI) is the standard of care for selected patients with severe aortic stenosis, irrespective of the surgical risk. Over the last two decades of TAVI practice, multiple limitations were identified. In addition, the extension of TAVI into a wider patient spectrum created new challenges.

Areas covered: This review provides an overview of emerging transcatheter heart valves (THVs) beyond the approved contemporary THVs for the treatment of aortic stenosis.

Expert opinion: The incidence of degenerative aortic stenosis is expected to increase with more aging of the population. Therefore, TAVI needs to meet this increase in the number of patients indicated for aortic valve replacement alongside a wide and complex anatomical variability. An increasing number of Aortic THVs are available in the market. This includes upgraded iterations of contemporary devices and innovative devices developed by emerging manufacturers. The new devices aim for the reduction or elimination of undesirable outcomes like paravalvular leakage and conduction disturbances requiring permanent pacemaker implantation. Alternatively, emerging THVs should provide feasibility regarding yet unproven TAVI indications like Bicuspid aortic valve, aortic regurgitation, or very large anatomy. Furthermore, some of the emerging THVs are designed to tackle the long-term durability issue of biological valves.

引言:经导管主动脉瓣植入术(TAVI)是选定的严重主动脉瓣狭窄患者的标准护理,无论手术风险如何。在过去二十年的TAVI实践中,发现了多种局限性。此外,TAVI扩展到更广泛的患者范围带来了新的挑战。涵盖领域:这篇综述概述了在批准的当代经导管心脏瓣膜治疗主动脉狭窄之外出现的经导管心脏瓣(THV)。专家意见:退行性主动脉瓣狭窄的发生率预计会随着人口老龄化的加剧而增加。因此,TAVI需要满足主动脉瓣置换术患者数量的增加以及广泛而复杂的解剖变异性。市场上有越来越多的主动脉THV可供选择。这包括当代设备的升级迭代和新兴制造商开发的创新设备。新设备旨在减少或消除不希望出现的结果,如瓣膜周围渗漏和需要植入永久性起搏器的传导障碍。或者,新兴的THV应提供尚未证实的TAVI适应症的可行性,如二尖瓣主动脉瓣、主动脉瓣反流或非常大的解剖结构。此外,一些新兴的THV旨在解决生物瓣膜的长期耐用性问题。
{"title":"Emerging transcatheter heart valve technologies for severe aortic stenosis.","authors":"Ahmed Elkoumy, Darren Mylotte, Hesham Elzomor, Angela McInerney, Osama Soliman","doi":"10.1080/17434440.2023.2277229","DOIUrl":"10.1080/17434440.2023.2277229","url":null,"abstract":"<p><strong>Introduction: </strong>Transcatheter aortic valve implantation (TAVI) is the standard of care for selected patients with severe aortic stenosis, irrespective of the surgical risk. Over the last two decades of TAVI practice, multiple limitations were identified. In addition, the extension of TAVI into a wider patient spectrum created new challenges.</p><p><strong>Areas covered: </strong>This review provides an overview of emerging transcatheter heart valves (THVs) beyond the approved contemporary THVs for the treatment of aortic stenosis.</p><p><strong>Expert opinion: </strong>The incidence of degenerative aortic stenosis is expected to increase with more aging of the population. Therefore, TAVI needs to meet this increase in the number of patients indicated for aortic valve replacement alongside a wide and complex anatomical variability. An increasing number of Aortic THVs are available in the market. This includes upgraded iterations of contemporary devices and innovative devices developed by emerging manufacturers. The new devices aim for the reduction or elimination of undesirable outcomes like paravalvular leakage and conduction disturbances requiring permanent pacemaker implantation. Alternatively, emerging THVs should provide feasibility regarding yet unproven TAVI indications like Bicuspid aortic valve, aortic regurgitation, or very large anatomy. Furthermore, some of the emerging THVs are designed to tackle the long-term durability issue of biological valves.</p>","PeriodicalId":94006,"journal":{"name":"Expert review of medical devices","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71490419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Selection criteria in the era of perfect competition for drug-eluting stents - a survey of interventional cardiologists in Japan: the selection-DES study. 药物洗脱支架完全竞争时代的选择标准——对日本介入心脏病专家的调查——选择DES研究。
Pub Date : 2023-07-01 Epub Date: 2023-11-24 DOI: 10.1080/17434440.2023.2277221
Satoru Hashimoto, Yoshihiro Motozawa, Toshiki Mano

Background: More than 20 years have passed since the first company introduced drug-eluting stent (DES) in 2002, but competing companies still have improved their DESs under regulatory approval. This study aimed to investigate the criteria for interventional cardiologists performing percutaneous coronary intervention (PCI) in selecting a DES.

Research design and methods: From 10 April 2023, to 30 April 2023, 3,422 cardiologists were requested to complete a questionnaire, of whom 126 responded to the survey.

Results: Overall, 86.5% of the respondents used Xience cobalt-chromium everolimus-eluting stent (Xience) in > 10% of PCI procedures. For Xience, brand loyalty and calcified lesions were important independent variables for the DES selection criteria. Ultimaster sirolimus-eluting stent (Ultimaster) was not affected by the clinical data delivered by the company, whereas the respondents were shown to seek support for their activities from the Ultimaster supplier. The relationship with the company and/or sales representative and the planned surgical procedure affected the use of Coroflex ISAR NEO sirolimus-eluting polymer-free stent.

Conclusions: Patient background and lesion characteristics had little impact on the DES selection criteria, suggesting that DES performance has already reached its physical limitations to the extent that respondents may not value further improvements in performance or characteristics of DES.

背景:20多个 自2002年第一家公司推出药物洗脱支架(DES)以来,几年过去了,但竞争公司仍在监管部门的批准下改进了其DES。本研究旨在调查介入心脏病专家进行经皮冠状动脉介入治疗(PCI)选择DES的标准。研究设计和方法:从2023年4月10日到2023年四月30日,3422名心脏病专家被要求填写问卷,其中126人对调查做出了回应。结果:总体而言,86.5%的受访者在 > PCI手术的10%。对于Xience来说,品牌忠诚度和钙化病变是DES选择标准的重要自变量。Ultimaster西罗莫司洗脱sten(Ultimaster)不受该公司提供的临床数据的影响,而受访者则向Ultimaster供应商寻求对其活动的支持。与公司和/或销售代表的关系以及计划的手术程序影响了Coroflex ISAR NEO西罗莫司洗脱聚合物无支架的使用。结论:患者背景和病变特征对DES的选择标准几乎没有影响,这表明DES的性能已经达到了其物理极限,受访者可能不重视DES性能或特征的进一步改进。
{"title":"Selection criteria in the era of perfect competition for drug-eluting stents - a survey of interventional cardiologists in Japan: the selection-DES study.","authors":"Satoru Hashimoto, Yoshihiro Motozawa, Toshiki Mano","doi":"10.1080/17434440.2023.2277221","DOIUrl":"10.1080/17434440.2023.2277221","url":null,"abstract":"<p><strong>Background: </strong>More than 20 years have passed since the first company introduced drug-eluting stent (DES) in 2002, but competing companies still have improved their DESs under regulatory approval. This study aimed to investigate the criteria for interventional cardiologists performing percutaneous coronary intervention (PCI) in selecting a DES.</p><p><strong>Research design and methods: </strong>From 10 April 2023, to 30 April 2023, 3,422 cardiologists were requested to complete a questionnaire, of whom 126 responded to the survey.</p><p><strong>Results: </strong>Overall, 86.5% of the respondents used Xience cobalt-chromium everolimus-eluting stent (Xience) in > 10% of PCI procedures. For Xience, brand loyalty and calcified lesions were important independent variables for the DES selection criteria. Ultimaster sirolimus-eluting stent (Ultimaster) was not affected by the clinical data delivered by the company, whereas the respondents were shown to seek support for their activities from the Ultimaster supplier. The relationship with the company and/or sales representative and the planned surgical procedure affected the use of Coroflex ISAR NEO sirolimus-eluting polymer-free stent.</p><p><strong>Conclusions: </strong>Patient background and lesion characteristics had little impact on the DES selection criteria, suggesting that DES performance has already reached its physical limitations to the extent that respondents may not value further improvements in performance or characteristics of DES.</p>","PeriodicalId":94006,"journal":{"name":"Expert review of medical devices","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71416347","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of telemedicine in obstetrics and gynecology: an experience at tertiary care center. 远程医疗在妇产科的作用:三级护理中心的经验。
Pub Date : 2023-07-01 Epub Date: 2023-11-24 DOI: 10.1080/17434440.2023.2264768
Aruna Singh, Amit Agarwal, Geetika Thakur, Sonu Goel, Meenu Singh

Background: The telemedicine/telehealth is well established and rapidly evolving innovation in modern practice of medicine. It is used in nearly every aspect of obstetrics and gynecology. Telehealth intervention may reduce the need for in-person visits amongst high-risk obstetric patients. It is an effective innovation for chronic gynecological conditions.

Research design and methods: This was a prospective, observational study where the online platform 'e-Sanjeevani' was used. It was a health care worker to doctor (specialist) consultation regarding the patient. After an interaction, provisional diagnosis and management plan was made, and an electronic prescription for the same was generated and printed at the patient's end.

Results: A total of 3219 patients were attended in 10 months. The majority of the cases had a gynecological problem (71.5%), with menstrual irregularity being the commonest. Among pregnant patients, consultations for early pregnancy complications were made in 29% of the cases. 5.8% were referred because of some surgical intervention.

Conclusion: Non-emergency patients who can be managed medically can be prevented from unnecessary visits to the hospital and managed through teleconsultation, which decreases the burden of patient load at the tertiary center.

背景:远程医疗/远程医疗是现代医学实践中建立良好并迅速发展的创新。它几乎应用于妇产科的各个方面。远程医疗干预可以减少高危产科患者的亲自就诊需求。它是治疗慢性妇科疾病的有效创新。研究设计和方法:这是一项前瞻性的观察性研究,使用了在线平台“e-Sanjeevani”。这是一位医护人员对医生(专家)就病人进行的咨询。在互动之后,制定了临时诊断和管理计划,并在患者端生成并打印了电子处方。结果:共有3219名患者在10个 月。大多数病例有妇科问题(71.5%),月经不规律是最常见的。在妊娠患者中,29%的病例进行了妊娠早期并发症的咨询。5.8%的患者因某种手术干预而转诊。结论:可以通过医疗管理的非急诊患者可以避免不必要的就诊,并通过远程会诊进行管理,从而减轻了三级中心的患者负担。
{"title":"Role of telemedicine in obstetrics and gynecology: an experience at tertiary care center.","authors":"Aruna Singh, Amit Agarwal, Geetika Thakur, Sonu Goel, Meenu Singh","doi":"10.1080/17434440.2023.2264768","DOIUrl":"10.1080/17434440.2023.2264768","url":null,"abstract":"<p><strong>Background: </strong>The telemedicine/telehealth is well established and rapidly evolving innovation in modern practice of medicine. It is used in nearly every aspect of obstetrics and gynecology. Telehealth intervention may reduce the need for in-person visits amongst high-risk obstetric patients. It is an effective innovation for chronic gynecological conditions.</p><p><strong>Research design and methods: </strong>This was a prospective, observational study where the online platform 'e-Sanjeevani' was used. It was a health care worker to doctor (specialist) consultation regarding the patient. After an interaction, provisional diagnosis and management plan was made, and an electronic prescription for the same was generated and printed at the patient's end.</p><p><strong>Results: </strong>A total of 3219 patients were attended in 10 months. The majority of the cases had a gynecological problem (71.5%), with menstrual irregularity being the commonest. Among pregnant patients, consultations for early pregnancy complications were made in 29% of the cases. 5.8% were referred because of some surgical intervention.</p><p><strong>Conclusion: </strong>Non-emergency patients who can be managed medically can be prevented from unnecessary visits to the hospital and managed through teleconsultation, which decreases the burden of patient load at the tertiary center.</p>","PeriodicalId":94006,"journal":{"name":"Expert review of medical devices","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41163246","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Expert review of medical devices
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1